Kratom Action Presents Regulatory Puzzle For FDA
This article was originally published in The Tan Sheet
The agency is seizing imports of kratom but industry seeks to clarify whether the substance, which in large doses can have narcotic effects, can be used in dietary supplements. Because FDA acknowledges kratom is a dietary ingredient, a ban as used for ephedra action may be up for consideration.
You may also be interested in...
Claims that promise too much point FDA to products marketed as supplements that warrant investigation for health fraud, CFSAN’s Corey Hilmas tells USP workshop on economically motivated adulteration.
FDA issues a consumer warning about the potentially lethal effects of DMAA, and promises to use “all available tools at its disposal to ensure the dietary supplements containing” the stimulant “are no longer distributed and available for sale.”
FDA’s warning letters to 10 marketers of DMAA-containing products might have a silver lining for the supplement industry as they suggest the agency may be flexible on its controversial interpretation of some provisions in the new dietary ingredient notification requirement.